Comparing two heart devices to prevent stroke in atrial fibrillation
Part of Heart & circulation clinical trials.
This study compares two devices (LAmbre and AMPLATZER Amulet) that are placed in the heart to prevent strokes in people with atrial fibrillation who cannot take blood thinners. If you join, you will be randomly assigned to get one of the two devices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have atrial fibrillation (a type of irregular heartbeat) and are at high risk for stroke, but you cannot take blood-thinning medicines long-term
- Your doctor has confirmed that the left atrial appendage (a small pouch in your heart) is shaped correctly for either device used in this study
- You do not need long-term blood thinners for other conditions, and you do not have other major heart or infection problems
- You are willing to follow the study schedule and take the medicines required after the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of closing a small pouch in the heart (the left atrial appendage) to help prevent strokes in people with atrial fibrillation (an irregular heartbeat). One method is less invasive, and the study aims to see if it is as safe and effective as the standard approach.
This trial tests a new device called LAmbre™ II that closes off a part of the heart called the left atrial appendage to help prevent strokes in people with atrial fibrillation who cannot take blood thinners.
This trial tests a device that closes off a small pouch in the heart where blood clots can form in people with atrial fibrillation. This may help reduce the risk of stroke without needing long-term blood thinners.
This study compares two similar devices that close off a small pocket in the heart to reduce stroke risk in people with atrial fibrillation who cannot take blood thinners safely. The goal is to see which device works better and is safer.
This trial is testing two ways to guide a procedure that closes a small pouch in the heart to lower the risk of stroke in people with atrial fibrillation. The goal is to see if one method is as good or better than the other.
This trial compares a heart device that can help prevent blood clots in the heart (called LAAO) versus long-term blood thinners for people who have atrial fibrillation and recently had a stent placed. It aims to see which approach better prevents stroke and related blood-clot problems while keeping side effects manageable.
Hear when a new Left Atrial Appendage Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.